Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 14 studies | 34% ± 12% | |
epithelial cell | 7 studies | 31% ± 9% | |
respiratory goblet cell | 5 studies | 23% ± 5% | |
squamous epithelial cell | 4 studies | 44% ± 14% | |
secretory cell | 3 studies | 23% ± 4% | |
enterocyte | 3 studies | 20% ± 2% | |
brush cell | 3 studies | 19% ± 1% |
Insufficient scRNA-seq data for expression of TJP3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 99% | 675.28 | 325 / 328 | 90% | 56.47 | 160 / 178 |
thymus | 100% | 1482.55 | 652 / 653 | 86% | 25.72 | 523 / 605 |
stomach | 77% | 2826.96 | 275 / 359 | 97% | 69.14 | 277 / 286 |
prostate | 82% | 831.53 | 202 / 245 | 77% | 13.36 | 389 / 502 |
lung | 91% | 1049.58 | 525 / 578 | 68% | 27.69 | 784 / 1155 |
breast | 58% | 807.44 | 267 / 459 | 95% | 55.03 | 1061 / 1118 |
intestine | 55% | 3489.05 | 534 / 966 | 97% | 76.17 | 512 / 527 |
liver | 100% | 812.42 | 225 / 226 | 50% | 12.33 | 205 / 406 |
kidney | 100% | 1019.25 | 89 / 89 | 34% | 7.78 | 306 / 901 |
bladder | 48% | 601.52 | 10 / 21 | 78% | 35.92 | 393 / 504 |
esophagus | 40% | 1469.27 | 576 / 1445 | 62% | 44.87 | 113 / 183 |
ovary | 1% | 2.34 | 2 / 180 | 93% | 34.10 | 398 / 430 |
skin | 72% | 763.59 | 1300 / 1809 | 0% | 0.04 | 1 / 472 |
uterus | 9% | 141.47 | 15 / 170 | 61% | 30.69 | 282 / 459 |
tonsil | 0% | 0 | 0 / 0 | 58% | 26.36 | 26 / 45 |
peripheral blood | 10% | 35.07 | 89 / 929 | 0% | 0 | 0 / 0 |
muscle | 8% | 28.38 | 61 / 803 | 0% | 0 | 0 / 0 |
spleen | 7% | 18.90 | 17 / 241 | 0% | 0 | 0 / 0 |
adrenal gland | 0% | 1.63 | 1 / 258 | 1% | 0.31 | 3 / 230 |
adipose | 1% | 7.52 | 18 / 1204 | 0% | 0 | 0 / 0 |
brain | 0% | 0.62 | 6 / 2642 | 0% | 0.04 | 2 / 705 |
blood vessel | 0% | 0.60 | 2 / 1335 | 0% | 0 | 0 / 0 |
heart | 0% | 0.44 | 1 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0090557 | Biological process | establishment of endothelial intestinal barrier |
GO_0150105 | Biological process | protein localization to cell-cell junction |
GO_1905605 | Biological process | positive regulation of blood-brain barrier permeability |
GO_0098609 | Biological process | cell-cell adhesion |
GO_0035633 | Biological process | maintenance of blood-brain barrier |
GO_0045216 | Biological process | cell-cell junction organization |
GO_0030054 | Cellular component | cell junction |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005886 | Cellular component | plasma membrane |
GO_0005923 | Cellular component | bicellular tight junction |
GO_0005634 | Cellular component | nucleus |
GO_0050839 | Molecular function | cell adhesion molecule binding |
GO_0005515 | Molecular function | protein binding |
Gene name | TJP3 |
Protein name | TJP3 protein Tight junction protein ZO-3 (Tight junction protein 3) (Zona occludens protein 3) (Zonula occludens protein 3) Tight junction protein 3 |
Synonyms | ZO3 |
Description | FUNCTION: TJP1, TJP2, and TJP3 are closely related scaffolding proteins that link tight junction (TJ) transmembrane proteins such as claudins, junctional adhesion molecules, and occludin to the actin cytoskeleton . The tight junction acts to limit movement of substances through the paracellular space and as a boundary between the compositionally distinct apical and basolateral plasma membrane domains of epithelial and endothelial cells. Binds and recruits PATJ to tight junctions where it connects and stabilizes apical and lateral components of tight junctions . Promotes cell-cycle progression through the sequestration of cyclin D1 (CCND1) at tight junctions during mitosis which prevents CCND1 degradation during M-phase and enables S-phase transition . With TJP1 and TJP2, participates in the junctional retention and stability of the transcription factor DBPA, but is not involved in its shuttling to the nucleus (By similarity). Contrary to TJP2, TJP3 is dispensable for individual viability, embryonic development, epithelial differentiation, and the establishment of TJs, at least in the laboratory environment (By similarity). . |
Accessions | K7ESC0 ENST00000541714.7 [O95049-1] K7EJ86 ENST00000539908.6 [O95049-5] ENST00000586032.5 ENST00000590545.5 ENST00000589378.5 [O95049-4] ENST00000587686.1 [O95049-3] O95049 Q2VPE5 |